AzTrials
AzTrials

Scaphoid FracturePhase 3NCT02605096

Pilot Study to Test the Feasibility of the Use of MRI in Suspected Scaphoid Fractures

A Phase 3 study testing MRI and X-ray in people with Scaphoid Fracture, run by Guy's and St Thomas' NHS Foundation Trust.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This pilot study aims to test the feasibility and work flows associated with using MRI as the initial imaging modality in the investigation of patients presenting with suspected scaphoid fracture. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Scaphoid Fracture
What is being tested?
MRI and X-ray
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
No sites listed yet
Study dates
1 Nov 2015to 1 Apr 2016
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients considered to be suitable for the proposed pathway include every patient aged 16 years old or above, presenting at A\&E/UCC between 8:00am and 4:00pm (Monday to Friday), with at least one of the following:
  • Isolated pain / tenderness over the Anatomical Snuff Box (ASB) or scaphoid tubercle or pain in the scaphoid region during axial loading of the 1st metacarpal.
  • History of recent fall (< 14 days) on out-stretched hand (FOOSH), wrist injury or poor history associated with examination findings suggestive of scaphoid fracture.

Who cannot join

  • Patients presenting outside GSTT's catchment area not willing to be followed-up at GSTT;
  • Patients without suspected scaphoid fracture following an initial A\&E/UCC clinical triage;
  • Patients with scaphoid fracture not admitted through A\&E at St Thomas' Hospital or Urgent Care Centre at Guy's Hospital;
  • Patients presenting at ED/UCC on weekdays (Monday to Friday) before 8:00am or after 4:00pm
  • Patients presenting at ED/UCC on weekends or Bank Holidays;
  • Patients who lack capacity to give consent or participate in the study;
  • Patients that are already taking part in a clinical trial of an investigational medicinal products (CTIMPs);
  • Patient is unable or unsuitable to MRI

About this study

Official title: A Single Centre Randomised, Non-blinded, Prospective Pilot to Test the Feasibility Associated With the Use of MRI as the Initial Imaging Modality in the Investigation of Patients Presenting With Suspected Scaphoid Fracture

This pilot study aims to test the feasibility and work flows associated with using MRI as the initial imaging modality in the investigation of patients presenting with suspected scaphoid fracture.

This pilot will be used to inform the design of a study that will aim to evaluate whether the proposed intervention is likely to generate cost-savings whilst improving or maintaining overall patient quality of life and satisfaction.

Read the detailed description

The present pilot study is designed to assess the feasibility of using MRI as the initial imaging modality in the investigation of patients presenting with suspected scaphoid fracture at the Emergency department or Urgent Care Centre. This study will inform the design of a study that will aim to evaluate whether the proposed intervention is likely to generate cost-savings whilst improving or maintaining overall patient quality of life and satisfaction.

Patients with a suspected scaphoid fracture will be randomised to receive standard of care using 4-view plain x-ray (control group) as the first imaging modality or MRI examination as the first imaging modality.

Being tested
MRI, X-ray
Keywords
suspected scaphoid fracture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRIProcedure or surgery

    Magnetic Resonance Imaging Scan

  • X-rayProcedure or surgery

    X-ray exam (conventional radiography)

Study groups in NCT02605096
Study groupRoleWhat they receive
MRI groupExperimentalThis arm assess the use of MRI as the first line examination of suspected scaphoid fracture (replacing conventional plain x-ray). Patients with negative findings will receive a splint and contact card to a specialist wrist clinic if the pain persists for ten to fourteen days after initial presentation. Patients with positive findings will receive a plaster cast and undergo a CT scan (to evaluate displacement) and will be referred to the fracture clinic. Furthermore, if the CT scan confirms a displaced fracture, that might require surgery, the patient should be seen by a Hand Specialist at fracture clinic. All patients enrolled in the pilot should undergo a 4-view plain x-ray 3 months after the initial ED/UCC presentation.
Receives: Procedure: MRI
X-ray groupActive comparatorThis arm is the current standard of care pathway for the diagnosis of patients with suspected scaphoid fracture. This includes an initial clinical assessment on arrival to the Emergency Department of Urgent Care Centre followed by a plain x-ray (using a 4-view scaphoid protocol). Patients with negative/positive findings for scaphoid fracture in the initial X-ray will be immobilised with a splint/plaster cast. All patients will be referred to an initial fracture clinic and a proportion of patients are likely to require additional imaging scans (usually CT but also MRI) and follow-up appointments in the fracture clinic. All patients enrolled in the pilot should undergo a 4-view plain x-ray 3 months after the initial ED/UCC presentation.
Receives: Procedure: X-ray

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time elapsed (measured in hours and minutes) from A&E presentation to study recruitment.

    Please note that the submitted study is a pilot to test feasibility of main study. Due to the recruitment of patients from A\&E, informed consent will need to be obtained for the study without negatively impacting clinical care (E.g Delay to treatment of patient with scaphoid fracture).

    Measured: 1 month

  2. Recruitment rate

    Number of patients recruited divided by total number of patients eligible and approached

    Measured: 1 month

  3. The proportion of mandatory fields of the Case Report Form completed including eligibility criteria, medical examination and history, patient demographics, randomisation and documents checklist.

    This will test the study's data collection procedures.

    Measured: 1 month

  4. Time elapsed (measured in hours and minutes) from A&E presentation to the initial MRI or x-ray investigation.

    Measured: 1 month

  5. Time elapsed (measured in hours and minutes) from A&E presentation to treatment (either plaster cast or removable splint).

    Measured: 1 month

  6. Time elapsed (measured in hours and minutes) from A&E presentation to A&E discharge.

    Measured: 1 month

Secondary outcomes (4)
  1. Study attrition rate

    % patients lost to follow-up

    Measured: 4 months

  2. The proportion of patient who completed the EQ-5D-5L questionnaire.

    Data collected will be used to inform the main study and will determine if any change in processes is required, prior to commencing main study.

    Measured: 4 months

  3. The proportion of patient who completed the patient resource use diary.

    Data collected will be used to inform the main study and will determine if any change in processes is required, prior to commencing main study.

    Measured: 4 months

  4. The proportion of patient who completed the patient experience questionnaire.

    Data collected will be used to inform the main study and will determine if any change in processes is required, prior to commencing main study.

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Nov 2015 (estimated)
  2. Study start1 Nov 2015
  3. Primary completion1 Apr 2016
  4. Study completion1 Apr 2016

Why it stopped: Recruitment strategy not working. This information was really useful to design a randomised controlled trial.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02605096
Sponsor's protocol ID
RJ115/N294
Status last verified
Aug 2017
First submitted
5 Nov 2015
Last updated
8 Aug 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing MRI and X-ray in people with Scaphoid Fracture, run by Guy's and St Thomas' NHS Foundation Trust.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 8 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: Recruitment strategy not working. This information was really useful to design a randomised controlled trial.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time elapsed (measured in hours and minutes) from A&E presentation to study recruitment. (time frame: 1 month). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in